nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K1—hindbrain—autistic disorder	0.032	0.128	CbGeAlD
Trametinib—MAP2K1—brainstem—autistic disorder	0.0183	0.0735	CbGeAlD
Trametinib—MAP2K1—eye—autistic disorder	0.0179	0.0716	CbGeAlD
Trametinib—MAP2K1—forebrain—autistic disorder	0.0177	0.071	CbGeAlD
Trametinib—MAP2K1—telencephalon—autistic disorder	0.0163	0.0652	CbGeAlD
Trametinib—MAP2K2—forebrain—autistic disorder	0.0156	0.0625	CbGeAlD
Trametinib—MAP2K2—telencephalon—autistic disorder	0.0143	0.0574	CbGeAlD
Trametinib—MAP2K1—digestive system—autistic disorder	0.0124	0.0498	CbGeAlD
Trametinib—MAP2K2—digestive system—autistic disorder	0.0109	0.0438	CbGeAlD
Trametinib—MAP2K1—head—autistic disorder	0.0101	0.0406	CbGeAlD
Trametinib—MAP2K1—nervous system—autistic disorder	0.00961	0.0385	CbGeAlD
Trametinib—MAP2K1—central nervous system—autistic disorder	0.00925	0.0371	CbGeAlD
Trametinib—MAP2K1—cerebellum—autistic disorder	0.00904	0.0362	CbGeAlD
Trametinib—MAP2K2—head—autistic disorder	0.00892	0.0358	CbGeAlD
Trametinib—MAP2K2—nervous system—autistic disorder	0.00846	0.0339	CbGeAlD
Trametinib—MAP2K2—central nervous system—autistic disorder	0.00814	0.0326	CbGeAlD
Trametinib—MAP2K2—cerebellum—autistic disorder	0.00796	0.0319	CbGeAlD
Trametinib—MAP2K1—brain—autistic disorder	0.00734	0.0294	CbGeAlD
Trametinib—MAP2K2—brain—autistic disorder	0.00647	0.0259	CbGeAlD
Trametinib—CYP3A4—digestive system—autistic disorder	0.00257	0.0103	CbGeAlD
Trametinib—CYP2C8—brain—autistic disorder	0.00224	0.00898	CbGeAlD
Trametinib—CYP3A4—nervous system—autistic disorder	0.00198	0.00795	CbGeAlD
Trametinib—CYP3A4—central nervous system—autistic disorder	0.00191	0.00766	CbGeAlD
Trametinib—MAP2K1—Signaling Pathways—GABBR1—autistic disorder	9.82e-05	0.000131	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADM—autistic disorder	9.82e-05	0.000131	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PRL—autistic disorder	9.79e-05	0.00013	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PRL—autistic disorder	9.66e-05	0.000129	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EIF4E—autistic disorder	9.65e-05	0.000129	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PLA2G4A—autistic disorder	9.6e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PDE4B—autistic disorder	9.57e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AVP—autistic disorder	9.55e-05	0.000127	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—MAPK1—autistic disorder	9.55e-05	0.000127	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	9.53e-05	0.000127	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC25A12—autistic disorder	9.43e-05	0.000126	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—INPP1—autistic disorder	9.37e-05	0.000125	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ACADSB—autistic disorder	9.37e-05	0.000125	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—OPRM1—autistic disorder	9.27e-05	0.000123	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC19A1—autistic disorder	9.17e-05	0.000122	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GZMB—autistic disorder	9.06e-05	0.000121	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PRL—autistic disorder	9.04e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PLA2G4A—autistic disorder	8.98e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—BCL2—autistic disorder	8.93e-05	0.000119	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—MAPK1—autistic disorder	8.93e-05	0.000119	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR1B—autistic disorder	8.8e-05	0.000117	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—OXT—autistic disorder	8.8e-05	0.000117	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—HRAS—autistic disorder	8.61e-05	0.000115	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MEF2C—autistic disorder	8.53e-05	0.000114	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HTR2A—autistic disorder	8.49e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GZMB—autistic disorder	8.48e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—HRAS—autistic disorder	8.47e-05	0.000113	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	8.43e-05	0.000112	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—BCL2—autistic disorder	8.36e-05	0.000111	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—BTD—autistic disorder	8.35e-05	0.000111	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL6—autistic disorder	8.24e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR1B—autistic disorder	8.23e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—OXT—autistic disorder	8.23e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD1—autistic disorder	8.18e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TSC1—autistic disorder	8.18e-05	0.000109	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADSL—autistic disorder	8.17e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—IL6—autistic disorder	8.11e-05	0.000108	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—HRAS—autistic disorder	8.06e-05	0.000107	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—XDH—autistic disorder	8.02e-05	0.000107	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MEF2C—autistic disorder	7.98e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NTRK2—autistic disorder	7.95e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HTR2A—autistic disorder	7.94e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—HRAS—autistic disorder	7.92e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DRD3—autistic disorder	7.92e-05	0.000106	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—STX1A—autistic disorder	7.87e-05	0.000105	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NPAS2—autistic disorder	7.87e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL5—autistic disorder	7.75e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-A—autistic disorder	7.73e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL6—autistic disorder	7.71e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—HRAS—autistic disorder	7.66e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CALCA—autistic disorder	7.66e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TSC1—autistic disorder	7.65e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD1—autistic disorder	7.65e-05	0.000102	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TCN2—autistic disorder	7.6e-05	0.000101	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—IL6—autistic disorder	7.58e-05	0.000101	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PRKCB—autistic disorder	7.44e-05	9.92e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NTRK2—autistic disorder	7.44e-05	9.92e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DRD3—autistic disorder	7.41e-05	9.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—PTEN—autistic disorder	7.4e-05	9.86e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TSC2—autistic disorder	7.37e-05	9.82e-05	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—IL6—autistic disorder	7.34e-05	9.77e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL5—autistic disorder	7.25e-05	9.66e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADA—autistic disorder	7.25e-05	9.66e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-A—autistic disorder	7.23e-05	9.63e-05	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—HRAS—autistic disorder	7.17e-05	9.55e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	7.17e-05	9.55e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CALCA—autistic disorder	7.16e-05	9.55e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MTHFR—autistic disorder	7.15e-05	9.53e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HLA-A—autistic disorder	7.13e-05	9.5e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PIK3CG—autistic disorder	7.12e-05	9.49e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TDO2—autistic disorder	7.1e-05	9.46e-05	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—POMC—autistic disorder	7.08e-05	9.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DRB1—autistic disorder	7.06e-05	9.4e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PRKCB—autistic disorder	6.97e-05	9.28e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—PTEN—autistic disorder	6.92e-05	9.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TSC2—autistic disorder	6.9e-05	9.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—IL6—autistic disorder	6.86e-05	9.14e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	6.86e-05	9.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—MAPK1—autistic disorder	6.81e-05	9.08e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TSC2—autistic disorder	6.81e-05	9.07e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PRKCB—autistic disorder	6.8e-05	9.06e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—POMC—autistic disorder	6.78e-05	9.04e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRL—autistic disorder	6.76e-05	9.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTHFR—autistic disorder	6.69e-05	8.92e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DHCR7—autistic disorder	6.68e-05	8.9e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HLA-A—autistic disorder	6.67e-05	8.89e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PIK3CG—autistic disorder	6.67e-05	8.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APOE—autistic disorder	6.66e-05	8.87e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—RORA—autistic disorder	6.61e-05	8.81e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DRB1—autistic disorder	6.6e-05	8.8e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EGF—autistic disorder	6.43e-05	8.57e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ADRB2—autistic disorder	6.42e-05	8.55e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—MAPK1—autistic disorder	6.37e-05	8.49e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TSC2—autistic disorder	6.37e-05	8.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PRKCB—autistic disorder	6.36e-05	8.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—POMC—autistic disorder	6.34e-05	8.45e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—EXT1—autistic disorder	6.33e-05	8.43e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC6A8—autistic disorder	6.33e-05	8.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRL—autistic disorder	6.33e-05	8.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APOE—autistic disorder	6.23e-05	8.3e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS2—autistic disorder	6.21e-05	8.27e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MAOB—autistic disorder	6.2e-05	8.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DAO—autistic disorder	6.04e-05	8.05e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AVP—autistic disorder	6.03e-05	8.03e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EGF—autistic disorder	6.02e-05	8.02e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—MAPK1—autistic disorder	6.02e-05	8.02e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APC—autistic disorder	6.01e-05	8.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADRB2—autistic disorder	6e-05	8e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF2—autistic disorder	6e-05	8e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EGF—autistic disorder	5.94e-05	7.92e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—autistic disorder	5.9e-05	7.86e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS2—autistic disorder	5.81e-05	7.74e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—UPB1—autistic disorder	5.79e-05	7.71e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TPH2—autistic disorder	5.76e-05	7.67e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PLA2G4A—autistic disorder	5.67e-05	7.55e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DPYD—autistic disorder	5.67e-05	7.55e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AVP—autistic disorder	5.64e-05	7.51e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—MAPK1—autistic disorder	5.63e-05	7.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APC—autistic disorder	5.62e-05	7.49e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF2—autistic disorder	5.62e-05	7.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EGF—autistic disorder	5.56e-05	7.41e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MEF2C—autistic disorder	5.51e-05	7.35e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—HRAS—autistic disorder	5.47e-05	7.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ASMT—autistic disorder	5.38e-05	7.17e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTM5—autistic disorder	5.38e-05	7.17e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ITGB3—autistic disorder	5.37e-05	7.16e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	5.32e-05	7.09e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PLA2G4A—autistic disorder	5.3e-05	7.07e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CACNA1C—autistic disorder	5.27e-05	7.02e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—autistic disorder	5.23e-05	6.97e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SERPINE1—autistic disorder	5.23e-05	6.96e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—BCL2—autistic disorder	5.2e-05	6.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MEF2C—autistic disorder	5.16e-05	6.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFNG—autistic disorder	5.16e-05	6.87e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—HRAS—autistic disorder	5.12e-05	6.82e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—autistic disorder	5.07e-05	6.75e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC25A12—autistic disorder	5.06e-05	6.74e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ITGB3—autistic disorder	5.03e-05	6.7e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HTR2A—autistic disorder	5.02e-05	6.68e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL2—autistic disorder	5.01e-05	6.68e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC19A1—autistic disorder	4.92e-05	6.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—autistic disorder	4.9e-05	6.53e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SERPINE1—autistic disorder	4.89e-05	6.51e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—BCL2—autistic disorder	4.87e-05	6.49e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—HRAS—autistic disorder	4.83e-05	6.44e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFNG—autistic disorder	4.82e-05	6.43e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DHFR—autistic disorder	4.79e-05	6.39e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TSC2—autistic disorder	4.77e-05	6.35e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2A—autistic disorder	4.69e-05	6.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL2—autistic disorder	4.69e-05	6.25e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LEP—autistic disorder	4.66e-05	6.21e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOE—autistic disorder	4.66e-05	6.21e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—autistic disorder	4.62e-05	6.16e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL2—autistic disorder	4.58e-05	6.1e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—autistic disorder	4.56e-05	6.08e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—HRAS—autistic disorder	4.52e-05	6.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TSC2—autistic disorder	4.46e-05	5.94e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRKCB—autistic disorder	4.4e-05	5.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADSL—autistic disorder	4.39e-05	5.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOE—autistic disorder	4.36e-05	5.81e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LEP—autistic disorder	4.36e-05	5.81e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—autistic disorder	4.33e-05	5.76e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PTEN—autistic disorder	4.31e-05	5.74e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—XDH—autistic disorder	4.3e-05	5.73e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL2—autistic disorder	4.29e-05	5.71e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—autistic disorder	4.27e-05	5.69e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—STX1A—autistic disorder	4.22e-05	5.63e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NPAS2—autistic disorder	4.22e-05	5.63e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APC—autistic disorder	4.21e-05	5.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3CG—autistic disorder	4.21e-05	5.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EGF—autistic disorder	4.16e-05	5.54e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRKCB—autistic disorder	4.11e-05	5.48e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TCN2—autistic disorder	4.08e-05	5.43e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	4.04e-05	5.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PTEN—autistic disorder	4.03e-05	5.37e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—POMC—autistic disorder	4.01e-05	5.34e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTEN—autistic disorder	3.98e-05	5.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APC—autistic disorder	3.94e-05	5.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3CG—autistic disorder	3.94e-05	5.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EGF—autistic disorder	3.89e-05	5.19e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADA—autistic disorder	3.89e-05	5.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF1—autistic disorder	3.85e-05	5.13e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—MAPK1—autistic disorder	3.84e-05	5.11e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP19A1—autistic disorder	3.75e-05	5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—POMC—autistic disorder	3.75e-05	4.99e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTEN—autistic disorder	3.72e-05	4.96e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SERPINE1—autistic disorder	3.66e-05	4.88e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1—autistic disorder	3.61e-05	4.8e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—MAPK1—autistic disorder	3.59e-05	4.78e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—RORA—autistic disorder	3.55e-05	4.73e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	3.52e-05	4.69e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MAPK1—autistic disorder	3.5e-05	4.67e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—COMT—autistic disorder	3.49e-05	4.65e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTP1—autistic disorder	3.47e-05	4.63e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MAOA—autistic disorder	3.46e-05	4.62e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SERPINE1—autistic disorder	3.42e-05	4.56e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAT—autistic disorder	3.38e-05	4.5e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MAOB—autistic disorder	3.33e-05	4.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MAPK1—autistic disorder	3.28e-05	4.37e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MAPK1—autistic disorder	3.24e-05	4.31e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTM1—autistic disorder	3.19e-05	4.25e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PLA2G4A—autistic disorder	3.19e-05	4.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TPH2—autistic disorder	3.09e-05	4.12e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HRAS—autistic disorder	3.08e-05	4.1e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GPX1—autistic disorder	3.06e-05	4.07e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DPYD—autistic disorder	3.04e-05	4.05e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MAPK1—autistic disorder	3.03e-05	4.03e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL2—autistic disorder	2.96e-05	3.95e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—autistic disorder	2.95e-05	3.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HRAS—autistic disorder	2.88e-05	3.84e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CACNA1C—autistic disorder	2.83e-05	3.77e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—autistic disorder	2.82e-05	3.76e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HRAS—autistic disorder	2.81e-05	3.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTEN—autistic disorder	2.79e-05	3.71e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL2—autistic disorder	2.77e-05	3.69e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—autistic disorder	2.76e-05	3.67e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—autistic disorder	2.69e-05	3.59e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HRAS—autistic disorder	2.63e-05	3.51e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOE—autistic disorder	2.63e-05	3.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTEN—autistic disorder	2.61e-05	3.47e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HRAS—autistic disorder	2.6e-05	3.46e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DHFR—autistic disorder	2.57e-05	3.43e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—autistic disorder	2.52e-05	3.36e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—autistic disorder	2.49e-05	3.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HRAS—autistic disorder	2.43e-05	3.24e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3CG—autistic disorder	2.37e-05	3.16e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—autistic disorder	2.33e-05	3.1e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAPK1—autistic disorder	2.27e-05	3.02e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—POMC—autistic disorder	2.26e-05	3.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAPK1—autistic disorder	2.12e-05	2.82e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP19A1—autistic disorder	2.01e-05	2.68e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—COMT—autistic disorder	1.87e-05	2.5e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTP1—autistic disorder	1.86e-05	2.48e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MAOA—autistic disorder	1.86e-05	2.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HRAS—autistic disorder	1.82e-05	2.42e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAT—autistic disorder	1.81e-05	2.42e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—autistic disorder	1.8e-05	2.4e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—autistic disorder	1.74e-05	2.32e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTM1—autistic disorder	1.71e-05	2.28e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	1.71e-05	2.28e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HRAS—autistic disorder	1.7e-05	2.27e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GPX1—autistic disorder	1.64e-05	2.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—autistic disorder	1.63e-05	2.17e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTEN—autistic disorder	1.57e-05	2.09e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—autistic disorder	1.51e-05	2.02e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOE—autistic disorder	1.41e-05	1.88e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3CG—autistic disorder	1.27e-05	1.69e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—POMC—autistic disorder	1.21e-05	1.61e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—autistic disorder	9.66e-06	1.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTEN—autistic disorder	8.42e-06	1.12e-05	CbGpPWpGaD
